STELLAHEM
Live / Allowed — Notice of allowance issued (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99627985
- Mark type
- Word mark
- Filed
- 02 Feb 2026
- Published for opposition
- 23 Jun 2026
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of blood disorders; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders, and blood-based diseases; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders and blood-based diseases and to be infused to a human subject; pharmaceutical preparations for cell and gene therapy for the treatment of bone marrow; pharmaceutical preparations containing cells treated with vectors encoding proteins for elongating telomeres in blood cells; pharmaceutical preparations containing blood cells treated with vectors encoding ZSCAN4 proteins for elongating telomeres in the blood cells; pharmaceutical preparations containing blood cells treated with Sendai virus vectors encoding proteins for elongating telomeres in the blood cells
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 18 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jun 2026 — PUBLISHED FOR OPPOSITION
- 17 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2026 — ASSIGNED TO EXAMINER
- 02 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Feb 2026 — NEW APPLICATION ENTERED